CD44 and pancreatic neoplasm: Taken together, our results suggest that miR-23a partially promotes pancreatic cancer EMT and metastasis by targeting ESRP1 and regulating CD44 splicing as well as FGFR2 IIIb and FGFR2 IIIc mRNA levels (Figure 10E).